Anti-SARS-CoV-2 antibody detection in healthcare workers of two tertiary hospitals in Athens, Greece.
作者信息
Vlachoyiannopoulos Panayiotis, Alexopoulos Haris, Apostolidi Irini, Bitzogli Kleopatra, Barba Chrysanthi, Athanasopoulou Elpida, Dalakas Marinos, Tzioufas Athanasios
机构信息
Department of Pathophysiology, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece; Department of Pathophysiology, Laiko University Hospital, Athens, Greece.
Department of Pathophysiology, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
出版信息
Clin Immunol. 2020 Dec;221:108619. doi: 10.1016/j.clim.2020.108619. Epub 2020 Oct 27.
Abstract
摘要
相似文献
1
Anti-SARS-CoV-2 antibody detection in healthcare workers of two tertiary hospitals in Athens, Greece.
Clin Immunol. 2020 Dec;221:108619. doi: 10.1016/j.clim.2020.108619. Epub 2020 Oct 27.
2
Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.
J Hosp Infect. 2021 Feb;108:120-134. doi: 10.1016/j.jhin.2020.11.008. Epub 2020 Nov 16.
3
Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.
BMC Infect Dis. 2021 May 26;21(1):478. doi: 10.1186/s12879-021-06208-2.
4
Seroprevalence of SARS-CoV-2 antibodies among 925 staff members in an urban hospital accepting COVID-19 patients in Osaka prefecture, Japan: A cross-sectional study.
Medicine (Baltimore). 2021 Jun 25;100(25):e26433. doi: 10.1097/MD.0000000000026433.
5
Prevalence of SARS-CoV-2 Antibody in 2,935 Healthcare Workers at 6 Major Hospitals, Daegu, Korea.
J Korean Med Sci. 2021 Nov 8;36(43):e294. doi: 10.3346/jkms.2021.36.e294.
6
Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study.
Int J Hyg Environ Health. 2021 Mar;232:113671. doi: 10.1016/j.ijheh.2020.113671. Epub 2020 Nov 30.
7
High Rates of SARS-CoV-2 Family Transmission in Children of Healthcare Workers During the First Pandemic Wave in Madrid, Spain: Serologic Study.
Pediatr Infect Dis J. 2021 May 1;40(5):e185-e188. doi: 10.1097/INF.0000000000003088.
8
A cross-sectional study of SARS-CoV-2 seroprevalence among asymptomatic healthcare workers in a tertiary healthcare centre: Assessing the impact of PPE guidelines.
Indian J Med Microbiol. 2021 Oct-Dec;39(4):528-533. doi: 10.1016/j.ijmmb.2021.09.011. Epub 2021 Oct 20.
9
SARS-CoV-2 antibodies in Ontario health care workers during and after the first wave of the pandemic: a cohort study.
CMAJ Open. 2021 Oct 12;9(4):E929-E939. doi: 10.9778/cmajo.20210044. Print 2021 Oct-Dec.
10
SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala.
Ann Med. 2021 Dec;53(1):1956-1959. doi: 10.1080/07853890.2021.1993325.
引用本文的文献
1
Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies.
Eur J Intern Med. 2023 Jan;107:7-16. doi: 10.1016/j.ejim.2022.11.009. Epub 2022 Nov 10.
2
SARS-CoV-2 Sero-Surveillance in Greece: Evolution over Time and Epidemiological Attributes during the Pre-Vaccination Pandemic Era.
Diagnostics (Basel). 2022 Jan 25;12(2):295. doi: 10.3390/diagnostics12020295.
3
Characterization of IgG Antibody Response against SARS-CoV-2 (COVID-19) in the Cypriot Population.
Microorganisms. 2021 Dec 31;10(1):85. doi: 10.3390/microorganisms10010085.
4
A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases.
J Autoimmun. 2021 Dec;125:102743. doi: 10.1016/j.jaut.2021.102743. Epub 2021 Oct 28.
5
Half-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodies and Rule Compliance in German Hospital Employees.
Int J Environ Res Public Health. 2021 Oct 19;18(20):10972. doi: 10.3390/ijerph182010972.
6
SARS-CoV-2 Antigenemia as a Confounding Factor in Immunodiagnostic Assays: A Case Study.
Viruses. 2021 Jun 14;13(6):1143. doi: 10.3390/v13061143.
7
Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis.
EClinicalMedicine. 2021 Mar;33:100770. doi: 10.1016/j.eclinm.2021.100770. Epub 2021 Mar 8.
8
Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications.
Front Immunol. 2021 Feb 17;12:627285. doi: 10.3389/fimmu.2021.627285. eCollection 2021.
本文引用的文献
1
Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium.
JAMA. 2020 Jul 14;324(2):195-197. doi: 10.1001/jama.2020.11160.
2
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
Lancet. 2020 Aug 1;396(10247):313-319. doi: 10.1016/S0140-6736(20)31304-0. Epub 2020 Jun 11.
3
SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients.
J Clin Virol. 2020 Jul;128:104437. doi: 10.1016/j.jcv.2020.104437. Epub 2020 May 13.
4
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.
Immunity. 2020 Jun 16;52(6):971-977.e3. doi: 10.1016/j.immuni.2020.04.023. Epub 2020 May 3.
5
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.
J Thromb Haemost. 2020 Jul;18(7):1738-1742. doi: 10.1111/jth.14850. Epub 2020 Jun 24.
6
Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China.
J Infect. 2020 Apr;80(4):388-393. doi: 10.1016/j.jinf.2020.02.016. Epub 2020 Feb 26.
7
Clinical Characteristics of Coronavirus Disease 2019 in China.
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
Zotero 插件